A 45-year-old with bronchiectasis has thick purulent sputum, wheezing, oxygen need 3 L/min, pulmonary pressures elevated, and poor response to albuterol alone in the step-down unit. Which inhaled medication recommendation best targets secretions, inflammation and vascular tone?
Select an answer to reveal the explanation.
Short Explanation
You are matching each drug to its real job in sticky airways. Loosening mucus then calming inflammation works better, like wetting dishes before scrubbing them clean.
Full Explanation
Thick purulent sputum in bronchiectasis responds to mucolytic hydration with hypertonic saline to improve mucociliary clearance, bronchodilator pretreatment to prevent bronchospasm, inhaled corticosteroids or appropriate anti-inflammatory therapy for airway inflammation and wheezing when indicated, and careful oxygen titration to hypoxemia, while inhaled vasodilators are reserved for critical care pulmonary hypertension with monitoring. Continuous inhaled nitric oxide on the ward misplaces a critical care selective pulmonary vasodilator because it requires specialized delivery and monitoring, does not thin secretions, and is not ward maintenance for bronchiectasis. Nebulized lidocaine before clearance misuses topical anesthesia because routine lidocaine risks bronchospasm, numbs protective cough and gag, and has no mucolytic action to dissolve plugs. High-dose antitussives with dry oxygen suppresses needed clearance because cough is essential to mobilize purulent secretions in bronchiectasis and dry gas impairs mucociliary function, worsening retention and infection risk. Exam caveat is that NBRC expects mucolytics paired with bronchodilator pretreatment and distinction between anti-inflammatory and vasodilator indications, and practical check is to preassess FEV1 and SpO2, pretreat with albuterol, monitor bronchospasm and tolerance, and use humidified oxygen during clearance.